Secondary analysis of a placebo-controlled trial of grass pollen immunotherapy: subcutaneous immunotherapy preferentially depleted CRTH2hiCD27lo grass-specific CD4+ T cells, whereas sublingual immunotherapy depleted CRTH2loCD27hi cells; links with nasal symptoms were weak.
Secondary analysis
DeBerg et al. Differential effects of subcutaneous and sublingual immunotherapy on timothy grass-specific TH2 CD4+ T-cell subsets